RCS - BH Macro Limited - Results analysis from Kepler Trust Intelligence

BH MacroAnnouncement

06/04/2023 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230406:nRSF6845Va&default-theme=true

RNS Number : 6845V  BH Macro Limited  06 April 2023

BH Macro (BHMG)

06/04/2023

Results analysis from Kepler Trust Intelligence

Brevan Howard Capital Management LP (the "Manager") achieved excellent returns
in 2022 during a turbulent period in markets, the global economy and
geopolitics. The NAV per share rose by 21.91% for the Sterling share class,
which were impressive relative returns compared with other asset classes. In
the Chair, Richard Horlick's, view this absolute and relative performance
makes BH Macro Limited a cornerstone in investors' portfolios.

Coming into 2023, hopes that a soft landing would be achieved hit the skids in
March when the Fed and the ECB turned more hawkish on inflation and unleashed
a cascade of bank failures and retrenchments. The board is wholly independent
of the Brevan Howard group and maintains a regular dialogue with the manager
in order to assure itself of the quality of the investment team and supporting
systems, operations and infrastructure across the organisation. BH Macro's
Chair states that he believes that the trading team today is the strongest it
has ever been.

Brevan Howard observe that global imbalances, both within individual economies
as well as between them, in part due to economic desynchronisation, are at
generational extremes. As a consequence, the macro landscape looks set to
remain extremely interesting.

Kepler View

BH Macro invests all of its capital into the Brevan Howard Master Fund, the
flagship hedge fund run by Brevan Howard. 2022 proved a banner year for BH
Macro, delivering exactly as shareholders would have hoped by achieving a
strong NAV return at a time when the rest of their portfolio was having a
significantly tougher time. Importantly, the share price remained firm
throughout this period, and the sterling shares traded at an average premium
of 10.6% during the year, enabling the board to issue shares worth c. £185m.

More recently March 2023 was a tough month. As at 31st March 2023 the
estimated Net Asset Values was 404p, reflecting a decline of 4.33% over the
month, and -3.45% over the calendar year to date. We observe that many other
macro hedge fund strategies have also fallen significantly, many having been
negatively influenced by the very significant move in US interest rate
expectations that followed the collapse in Silicon Valley Bank.

The negative performance during March has unsurprisingly taken some of the
shine off the share price rating, having retreated to a modest premium to NAV
of 3.9% (as at 06/04/2023).

CLICK HERE TO READ THE FULL REPORT
(https://www.trustintelligence.co.uk/investor/articles/news-investor-results-analysis-bh-macro-apr-2023?utm_source=RNS&utm_medium=research)

Visit Kepler Trust Intelligence
(http://www.trustintelligence.co.uk/investor?utm_source=RNS&utm_medium=news)
for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has
prepared this report is aware that Kepler Partners LLP has a relationship with
the company covered in this report and/or a conflict of interest which may
impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of
investments can fall as well as rise and you may get back less than you
invested when you decide to sell your investments. It is strongly recommended
that if you are a private investor independent financial advice should be
taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients.
This report has been issued by Kepler Partners LLP, is based on factual
information only, is solely for information purposes only and any views
contained in it must not be construed as investment or tax advice or a
recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to,
or use by, any person or entity in any jurisdiction or country where such
distribution or use would be contrary to law or regulation or which would
subject Kepler Partners LLP to any registration requirement within such
jurisdiction or country. In particular, this website is exclusively for non-US
Persons. Persons who access this information are required to inform themselves
and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and
should not be construed as, investment advice. No representation or warranty,
express or implied, is given by any person as to the accuracy or completeness
of the information and no responsibility or liability is accepted for the
accuracy or sufficiency of any of the information, for any errors, omissions
or misstatements, negligent or otherwise. Any views and opinions, whilst given
in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation,
offer or solicitation to buy or sell or take any action in relation to any
investment mentioned herein. Any prices or quotations contained herein are
indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or
a connected person may have positions in or options on the securities detailed
in this report, and may buy, sell or offer to purchase or sell such securities
from time to time, but will at all times be subject to restrictions imposed by
the firm's internal rules. A copy of the firm's Conflict of Interest policy is
available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS
(http://www.trustintelligence.co.uk/investor/terms?utm_source=RNS&utm_medium=news)

Kepler Partners LLP is authorised and regulated by the Financial Conduct
Authority (FRN 480590), registered in England and Wales at 70 Conduit Street,
London W1S 2GF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSWFLMEDSEIL